GCNT2 Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP22141c
Background:
Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. The expression of the blood group I antigen in erythrocytes is determined by isoform C.
Other Names:
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C, N-acetylglucosaminyltransferase, 2.4.1.150, I-branching enzyme, IGNT, GCNT2, GCNT5, II, NACGT1
Target/Specificity:
The synthetic peptide sequence is selected from aa 129-141 of HUMAN GCNT2
Primary Accession: Q8NFS9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. The expression of the blood group I antigen in erythrocytes is determined by isoform C.
Other Names:
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C, N-acetylglucosaminyltransferase, 2.4.1.150, I-branching enzyme, IGNT, GCNT2, GCNT5, II, NACGT1
Target/Specificity:
The synthetic peptide sequence is selected from aa 129-141 of HUMAN GCNT2
Primary Accession: Q8NFS9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review